Cai Y, Sun R, He KF, Zhao YF, Zhao JH. Sclerotherapy for the
recurrent granulomatous epulis with pingyangmycin. Med Oral Patol Oral Cir Bucal. 2017 Mar 1;22
(2):e214-8.
doi:10.4317/medoral.21422
http://dx.doi.org/doi:10.4317/medoral.21422
1. Liu C, Qin ZP, Fan ZN, Zhao WJ, Wang YM, Wei FC, et
al. New treatment strategy
for granulomatous epulis: intralesional injection of propranolol. Med Hypotheses. 2012;78:327-9. |
|
|
|
2. Zheng JW, Zhou Q, Yang XJ, He
Y, Wang YA, Ye WM, et al. Intralesional injection of Pingyangmycin may be an effective
treatment for epulis. Med Hypotheses.
2009;72:453-4. |
|
|
|
3. Jafarzadeh H, Sanatkhani M, Mohtasham N. Oral pyogenic
granuloma: a review. J Oral Sci.
2006;48:167-75. |
|
|
|
4. Al-Khateeb T, Ababneh K. Oral pyogenic granuloma in Jordanians:
a retrospective analysis
of 108 cases. J Oral Maxillofac Surg.
2003;61:1285-8. |
|
|
|
5.
Gomes SR, Shakir QJ, Thaker
PV, Tavadia JK. Pyogenic
granuloma of the gingiva:
A misnomer? - A case report
and review of literature.
J Indian Soc Periodontol. 2013;17:514-9. |
|
|
|
6. Kuhl SR, Schulze RK, Kreft A, d'Hoedt B. Epulis granulomatosa as an oral
manifestation of Klippel-Trenaunay
syndrome. J Oral Pathol Med. 2006;35:576-8. |
|
|
|
7. Cai Y, Wang R, Yang SF, Zhao
YF, Zhao JH. Sclerotherapy
for the mucoceles of the anterior
lingual salivary glands with pingyangmycin. Oral Dis. 2014;20:473-6. |
|
|
|
8.
Taira JW, Hill TL, Everett MA. Lobular capillary
hemangioma (pyogenic granuloma) with
satellitosis. J Am Acad Dermatol. 1992;27:297-300. |
|
|
|
9. Meisheng X. Histopathologic study of esophageal squamous cell carcinoma treated preoperatively with Pingyangmycin. Chin Med J (Engl). 1979;92:343-8. |
|
|
|
10.
Gong JH, Liu XJ, Li Y, Zhen
YS. Pingyangmycin downregulates
the expression of EGFR
and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice. Cancer Chemother Pharmacol. 2012;69:1323-32. |
|
|
|
11. Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous
malformations with use of
pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg. 2004;33:463-6. |
|
|
|
12. Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF. Sclerotherapy of microcystic lymphatic malformations in oral
and facial regions. J Oral Maxillofac
Surg. 2009;67:251-6. |
|
|
|
13.
Zhang W, Chen G, Ren JG, Zhao YF. Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy
of venous malformations.
Br J Pharmacol. 2013;170:1210-20. |
|
|
|
14. Ichimiya M, Yoshikawa Y, Hamamoto Y, Muto M. Successful treatment of pyogenic granuloma
with injection of absolute ethanol. J Dermatol. 2004;31:342-4. |
|
|
|
15.
Moon SE, Hwang EJ, Cho
KH. Treatment of pyogenic
granuloma by sodium tetradecyl sulfate sclerotherapy.
Arch Dermatol.
2005;141:644-6. |
|
|
|
16. Parisi E, Glick PH, Glick M. Recurrent intraoral pyogenic granuloma with satellitosis treated with corticosteroids. Oral Dis.
2006;12:70-2. |
|
|
|
17. Zheng JW, Zhou Q, Yang XJ, Wang
YA, Fan XD, Zhou GY, et al. Treatment
guideline for hemangiomas
and vascular malformations of the
head and neck. Head Neck.
2010;32:1088-98. |
|
|
|
18.
Stuart S, Barnacle AM, Smith G, Pitt M, Roebuck DJ. Neuropathy after sodium tetradecyl sulfate sclerotherapy
of venous malformations
in children. Radiology.
2015;274:897-905. |
|
|